These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6321617)

  • 1. [Chemotherapy for ovarian cancer--drug selection and induced acute leukemia].
    Izumi R; Kawabata M; Nagasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):311-6. PubMed ID: 6321617
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Mucinous ovarian cancer.
    Omura GA
    Gynecol Oncol; 2005 Dec; 99(3):789; author reply 789-90. PubMed ID: 16125757
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogenic effects of chemotherapeutic compounds.
    Klein-Szanto AJ
    Prog Clin Biol Res; 1992; 374():167-74. PubMed ID: 1620702
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal toxicity of oxaliplatin.
    Labaye J; Sarret D; Duvic C; Hérody M; Didelot F; Nédélec G; Noël LH
    Nephrol Dial Transplant; 2005 Jun; 20(6):1275-6. PubMed ID: 15827046
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of chemotherapy on the prognosis of ovarian cancer].
    Sugawa T; Umesaki N; Yajima A; Satoh S; Terashima Y; Ochiai K; Tomoda Y; Kanoh T; Noda K; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1135-41. PubMed ID: 1333504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies and chemotherapeutic agents.
    Kyle RA
    Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic treatment of pseudomyxoma peritonei].
    Schneider T; Lotze W
    Zentralbl Gynakol; 1985; 107(24):1525-7. PubMed ID: 3004068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia following chemotherapy for ovarian cancer.
    Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S
    N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary myelodysplasia and leukemia following carboplatin and paclitaxel-containing chemotherapy for ovarian cancer].
    Abe A; Ikawa H; Muguruma H; Maeda Y
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1795-8. PubMed ID: 18931592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant platinum-based chemotherapy in patients with epithelial ovarian cancer: prognostic factors and final outcome.
    Grivas A; Lianos E; Internos I; Papaxoinis G; Tselepatiotis E; Ziras N; Athanasiou AE
    J BUON; 2010; 15(4):647-51. PubMed ID: 21229624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos HP; Efstathiou E; Salamalekis E; Farmakis D; Skarlos D; Briasoulis E; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2005 May; 97(2):436-41. PubMed ID: 15863142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intratumor chemotherapy of patients with cancer of the ovaries].
    Vinokurov VL; Mitrokhina MV
    Vopr Onkol; 1983; 29(8):58-61. PubMed ID: 6310891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Petru E; Schmähl D
    Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
    Travis LB; Holowaty EJ; Bergfeldt K; Lynch CF; Kohler BA; Wiklund T; Curtis RE; Hall P; Andersson M; Pukkala E; Sturgeon J; Stovall M
    N Engl J Med; 1999 Feb; 340(5):351-7. PubMed ID: 9929525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.
    Bamias A; Psaltopoulou T; Sotiropoulou M; Haidopoulos D; Lianos E; Bournakis E; Papadimitriou C; Rodolakis A; Vlahos G; Dimopoulos MA
    Cancer; 2010 Mar; 116(6):1462-8. PubMed ID: 20108307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of acute leukemia].
    Nakamura T; Ueda T
    Rinsho Byori; 1984 Sep; 32(9):967-74. PubMed ID: 6394825
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of chemo-immunotherapy of malignant ovarian tumors. Collaborated study with affiliated hospitals].
    Ota M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Aug; 37(8):1391-9. PubMed ID: 2995514
    [No Abstract]   [Full Text] [Related]  

  • 20. Synchronous ovarian endometrioid adenocarcinoma and endocervical mucinous adenocarcinoma.
    Huang YD; Hung YC; Yeh LS; Chiang IP; Zeng GC; Chang WC
    Taiwan J Obstet Gynecol; 2006 Sep; 45(3):264-7. PubMed ID: 17175478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.